Skip to main content

Dentsply Sirona Value Stock - Dividend - Research Selection

Dentsply sirona

ISIN: US24906P1093 , WKN: A2AF0E

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know

2026-04-18
A number of stocks jumped in the afternoon session as the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy costs.

Citigroup Initiates Coverage On Dentsply Sirona with Sell Rating, Announces Price Target of $10

2026-04-15
Citigroup analyst Daniel Grosslight initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Sell rating and announces Price Target of $10.

Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls

2026-04-15
Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls

$13+ Bn Dental Laboratories Market - Global Forecast to 2030 Featuring Dentsply Sirona, Envista, Ivoclar Vivadent AG, and Planmeca Oy

2026-04-13
The global dental laboratories market is forecast to grow from USD 9.20 billion in 2025 to USD 13.09 billion by 2030, with a CAGR of 7.3%. Key growth drivers include the increasing prevalence of dental disorders, an aging population, and the heightened focus on aesthetic dentistry. Technological advancements, such as digital workflows, CAD/CAM systems, and 3D printing, are accelerating market growth by enhancing production accuracy and customization. North America leads the market due to advance

Dentsply Sirona: Another Episode Of An Anticipated Recovery

2026-04-09
DENTSPLY SIRONA trades at historic lows after years of stagnation, underperformance, and failed growth initiatives. Learn why XRAY stock is a hold.

1 Small-Cap Stock with Competitive Advantages and 2 We Avoid

2026-04-03
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Does Revenue And Margin Pressure Undermine XRAY’s Efficiency-Driven Turnaround Story?

2026-04-03
Dentsply Sirona recently outlined past initiatives to boost growth through higher R&D spending on digital and implant platforms, expanded dealer partnerships, and a restructuring program targeting US$120 million in annual cost savings while reallocating cash from dividends toward debt reduction and share repurchases. However, the company’s ongoing revenue declines, margin pressure from tariffs and product mix, and weakness in key segments such as implants and SureSmile have raised fresh...

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

2026-04-01
XRAY bets on digital workflows and R&D expansion to fuel growth, but forex pressure and weak Europe demand cloud its near-term outlook.

3 Reasons to Avoid XRAY and 1 Stock to Buy Instead

2026-03-30
Although the S&P 500 is down 3.2% over the past six months, Dentsply Sirona’s stock price has fallen further to $11.47, losing shareholders 9.6% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.

3 Unprofitable Stocks with Questionable Fundamentals

2026-03-30
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.